Redefining Possibilities in HER2-Expressing mBC Care

Name: Redefining Possibilities in HER2-Expressing mBC Care
Start: 2025-12-10T14:30:00-06:00
End: 2025-12-10T15:30:00-06:00

December 10 @ 2:30 pm – 3:30 pm CST

A program focused on broadening choices in the management of HER2-expressing mBC, presented by Daiichi Sankyo, Inc. and AstraZeneca

These are not an official program of the San Antonio Breast Cancer Symposium®.

Presenter: Martin F Dietrich MD, PhD Medical Oncologist
Orlando, FL